Atlas Trials

A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies

Clinical trial NCT01416623 · TERMINATED

Trial details

NCT number
NCT01416623
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Cancer
Start date
2010-09-01
Primary completion
2012-12-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.